Hopkins AM, Proudman SM, Vitry AI, Sorich MJ, Cleland LG, Wiese MD. Ten years of publicly funded biological disease-modifying antirheumatic drugs in Australia. Med J Aust. 2016;204:64–8.
Article
PubMed
Google Scholar
Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320:1360–72.
Article
PubMed
Google Scholar
Longo DL, Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957–70.
Article
Google Scholar
Sairenji T, Collins KL, Evans DV. An update on inflammatory bowel disease. Prim Care. 2017;44:673–92.
Article
PubMed
Google Scholar
Ramiro S, Sepriano A, Chatzidionysiou K, Nam JL, Smolen JS, van der Heijde D, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis. 2017;76:1101–36.
Article
PubMed
Google Scholar
Nota I, Drossaert CH, Taal E, van de Laar MA. Patients’ considerations in the decision-making process of initiating disease-modifying antirheumatic drugs. Arthrit Care Res. 2015;67:956–64.
Article
Google Scholar
van Tuyl LH, Plass AM, Lems WF, Voskuyl AE, Kerstens PJ, Dijkmans BA, et al. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis. Rheum (Oxford, England). 2008;47:1571–6.
Article
CAS
Google Scholar
Goodacre LJ, Goodacre JA. Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication. Rheumatology (Oxford). 2004;43:583–6.
Article
CAS
Google Scholar
Townsend A, Backman CL, Adam P, Li LC. A qualitative interview study: patient accounts of medication use in early rheumatoid arthritis from symptom onset to early postdiagnosis. BMJ Open. 2013;3. https://doi.org/10.1136/bmjopen-2012-002164.
Kelly A, Tymms K, Tunnicliffe DJ, Sumpton D, Perera C, Fallon K, et al. Patients’ attitudes and experiences of disease-modifying antirheumatic drugs in rheumatoid arthritis and spondyloarthritis: a qualitative synthesis. Arthrit Care Res. 2018;70:525–32.
Article
CAS
Google Scholar
Smolen JS, Gladman D, McNeil HP, Mease PJ, Sieper J, Hojnik M, et al. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study. RMD Open. 2019;5:e000585.
Article
PubMed
PubMed Central
Google Scholar
Li L, Cui Y, Yin R, Chen S, Zhao Q, Chen H, et al. Medication adherence has an impact on disease activity in rheumatoid arthritis: a systematic review and meta-analysis. Patient Prefer Adher. 2017;11:1343–56.
Article
Google Scholar
McCulley C, Katz P, Trupin L, Yelin EH, Barton JL. Association of medication beliefs, self-efficacy, and adherence in a diverse cohort of adults with rheumatoid arthritis. J Rheumatol. 2018;45:1636–42.
Article
PubMed
PubMed Central
Google Scholar
Horne R, Albert A, Boone C. Relationship between beliefs about medicines, adherence to treatment, and disease activity in patients with rheumatoid arthritis under subcutaneous anti-TNFalpha therapy. Patient Prefer Adher. 2018;12:1099–111.
Article
Google Scholar
Durand C, Eldoma M, Marshall DA, Bansback N, Hazlewood GS. Patient preferences for disease-modifying antirheumatic drug treatment in rheumatoid arthritis: a systematic review. J Rheumatol. 2020;47:176–87.
Article
PubMed
Google Scholar
Fraenkel L, Cunningham M, Peters E. Subjective numeracy and preference to stay with the status quo. Med Decis Mak. 2015;35:6–11.
Article
Google Scholar
Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12:e1001885.
Article
PubMed
PubMed Central
Google Scholar
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (Clin Res ed). 2007;335:806–8.
Article
Google Scholar
WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, Oslo, Norway 2019 https://www.whocc.no/filearchive/publications/2019_guidelines_web.pdf. Accessed 2 Sept 2019.
Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ. 1995;310:170.
Article
CAS
PubMed
PubMed Central
Google Scholar
Commonwealth Department of Health and Aged Care, National Key Centre for Social Applications of Geographical Information Systems, Measuring remoteness: Accessibility/Remoteness Index of Australia (ARIA) revised edition, Commonwealth Department of Health and Aged Care, Canberra, 2001.
Australian Bureau of Statistics. s’ Australia 2012. Canberra: Australian Bureau of Statistics; 2012.
Google Scholar
IBM SPSS Statistics 2019. https://www.ibm.com/products/spss-statistics. Accessed 15 Nov 2019.
Charmaz K. Constructing grounded theory. 2nd ed. London: Sage; 2014.
Google Scholar
Afifi TD, Afifi WA. Uncertainty, information management, and disclosure decisions : theories and applications. New York: Routledge; 2009.
Google Scholar
Brashers DE. Communication and uncertainty management. J Commun. 2001;51:477–97.
Article
Google Scholar
Lambert SD, Loiselle CG. Health information—seeking behavior. Qual Health Res. 2007;17:1006–19.
Article
PubMed
Google Scholar
Dutta-Bergman MJ. Developing a profile of consumer intention to seek our health information beyond a doctor. Health Mark Q. 2003;21:91–112.
Article
PubMed
Google Scholar
Carpenter DM, Elstad EA, Blalock SJ, DeVellis RF. Conflicting medication information: prevalence, sources, and relationship to medication adherence. J Health Commun. 2014;19:67–81.
Article
PubMed
Google Scholar
Pollock K, Grime J, Baker E, Mantala K. Meeting the information needs of psychiatric inpatients: staff and patient perspectives. J Ment Health. 2004;13:389–401.
Article
Google Scholar
Han PKJ, Moser RP, Klein WMP. Perceived ambiguity about cancer prevention recommendations: Relationship to perceptions of cancer preventability, risk, and worry. J Health Commun. 2006;11(Supp.1):51–69.
Article
PubMed
PubMed Central
Google Scholar
Lim AY, Ellis C, Brooksby A, Gaffney K. Patient satisfaction with rheumatology practitioner clinics: can we achieve concordance by meeting patients’ information needs and encouraging participatory decision making? Ann Acad Med Singap. 2007;36:110–4.
PubMed
Google Scholar
Connelly K, Segan J, Lu A, Saini M, Cicuttini FM, Chou L, et al. Patients’ perceived health information needs in inflammatory arthritis: a systematic review. Semin Arthritis Rheum. 2018;48:900–10.
Article
PubMed
Google Scholar
Mus M, Kreijkamp-Kaspers S, McGuire T, Deckx L, van Driel M. What do health consumers want to know about childhood vaccination? An evaluation of data from an Australian medicines call Centre. Aust N Z J Public Health. 2017;41:74–9.
Article
PubMed
Google Scholar
Marrie RA, Walker JR, Graff LA, Patten SB, Bolton JM, Marriott JJ, et al. Gender differences in information needs and preferences regarding depression among individuals with multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis. Patient Educ Couns. 2019;102:1722–9.
Article
PubMed
Google Scholar
Pache DM, Hollingworth SA, van Driel ML, McGuire TM. Does consumer medicines interest reflect medicines use? An observational study comparing medicines call center queries with medicines use. Res Social Adm Pharm. 2019;15:440–7.
Article
PubMed
Google Scholar
Dragin N, Le Panse R, Berrih-Aknin S. Autoimmune disease predisposition: Aire << protects >> men. Med Sci (Paris). 2017;33:169–75.
Article
Google Scholar
Mathews AL, Coleska A, Burns PB, Chung KC. Evolution of patient decision-making regarding medical treatment of rheumatoid arthritis. Arthrit Care Res. 2016;68:318–24.
Article
Google Scholar
Dures E, Hewlett S, Ambler N, Jenkins R, Clarke J, Gooberman-Hill R. A qualitative study of patients’ perspectives on collaboration to support self-management in routine rheumatology consultations. BMC Musculoskelet Disord. 2016;17:129. https://doi.org/10.1186/s12891-016-0984-0.
Article
PubMed
PubMed Central
Google Scholar
Packham J, Arkell P, Sheeran T, Brownfield A, Cadwgan A, Ryan S. Patient experiences, attitudes and expectations towards receiving information about anti-TNF medication: a quantitative study. Clin Rheumatol. 2017;36:2595–600.
Article
PubMed
PubMed Central
Google Scholar
Pasma A, vant’ Spijker A, Luime JJ, Walter MJ, Busschbach JJ, Hazes JM. Facilitators and barriers to adherence in the initiation phase of Disease-modifying Antirheumatic Drug (DMARD) use in patients with arthritis who recently started their first DMARD treatment. J Rheumatol. 2015;42:379–85.
Article
PubMed
Google Scholar
Newby DA, Hill SR, Barker BJ, Drew AK, Henry DA. Drug information for consumers: should it be disease or medication specific? Results of a community survey. Aust N Z J Public Health. 2001;25:564–70.
Article
CAS
PubMed
Google Scholar
Ritschl V, Lackner A, Bostrom C, Mosor E, Lehner M, Omara M, et al. I do not want to suppress the natural process of inflammation: new insights on factors associated with non-adherence in rheumatoid arthritis. Arthrit Res Ther. 2018;20:234. https://doi.org/10.1186/s13075-018-1732-7.
Article
Google Scholar
Palominos PE, Gasparin AA, de Andrade NPB, Xavier RM, da Silva Chakr RM, Igansi F, et al. Fears and beliefs of people living with rheumatoid arthritis: a systematic literature review. Adv Rheumatol. 2018;58:1. https://doi.org/10.1186/s42358-018-0001-4.
Article
PubMed
Google Scholar
Rosen NO, Knauper B. A little uncertainty goes a long way: state and trait differences in uncertainty interact to increase information seeking but also increase worry. Health Commun. 2009;24:228–38.
Article
PubMed
Google Scholar
Hill J, Bird H. The development and evaluation of a drug information leaflet for patients with rheumatoid arthritis. Rheumatology. 2003;42:66–70.
Article
CAS
PubMed
Google Scholar
Crunkhorn C, van Driel M, Nguyen V, McGuire T. Children's medicine: what do consumers really want to know? J Paediatr Child Health. 2017;53:155–62.
Article
PubMed
Google Scholar
Hawke KL, McGuire TM, Ranmuthugala G, van Driel ML. What do consumers want to know about antibiotics? Analysis of a medicines call Centre database. Fam Pract. 2016;33:75–81.
Article
PubMed
Google Scholar
Therapeutic Goods of Australia. Humira. Product Information https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-03779-3. Accessed 1 Nov 2019.
Patane M, Ciriaco M, Chimirri S, Ursini F, Naty S, Grembiale RD, et al. Interactions among low dose of methotrexate and drugs used in the treatment of rheumatoid arthritis. Adv Pharmacol Sci. 2013;2013:313858. https://doi.org/10.1155/2013/313858.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bagatini F, Blatt CR, Maliska G, Trespash GV, Pereira IA, Zimmermann AF, et al. Potential drug interactions in patients with rheumatoid arthritis. Rev Bras Reumatol. 2011;51:20–39.
Article
PubMed
Google Scholar
Colebatch AN, Marks JL, van der Heijde DM, Edwards CJ. Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl. 2012;90:62–73.
Article
CAS
PubMed
Google Scholar
Luu B, Rodway GW. Does low-dose methotrexate deserve more respect from clinicians? Jaapa. 2017;30:12–5.
Article
PubMed
Google Scholar
Hoffmann TC, Del Mar C. Patients’ expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Intern Med. 2015;175:274–86.
Article
PubMed
Google Scholar
Woolf SH. The price of false beliefs: unrealistic expectations as a contributor to the health care crisis. Ann Fam Med. 2012;10:491–4.
Article
PubMed
PubMed Central
Google Scholar
Ackerman IN, Jordan JE, Van Doornum S, Ricardo M, Briggs AM. Understanding the information needs of women with rheumatoid arthritis concerning pregnancy, post-natal care and early parenting: a mixed-methods study. BMC Musculoskelet Disord. 2015;16:194. https://doi.org/10.1186/s12891-015-0657-4.
Article
PubMed
PubMed Central
Google Scholar
Micu MC, Ostensen M, Villiger PM, Micu R, Ionescu R. Paternal exposure to antirheumatic drugs—what physicians should know: review of the literature. Semin Arthritis Rheum. 2018;48:343–55.
Article
CAS
PubMed
Google Scholar
van Hulst LT, Kievit W, van Bommel R, van Riel PL, Fraenkel L. Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: results of a maximum difference scaling experiment. Arthritis Care Res. 2011;63:1407–14.
Article
Google Scholar
Verhoef LM, Selten EMH, Vriezekolk JE, de Jong AJL, van den Hoogen FHJ, den Broeder AA, et al. The patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: a mixed methods study. Rheumatology (Oxford). 2018;57:1947–55.
Article
Google Scholar
Danila M, Chen L, O'Beirne R, Ruderman E, Harrold L, Melnick J, et al. Patient- and physician-reported barriers to achieving rheumatoid arthritis (RA) disease control. Ann Rheum Dis. 2018;77(s2):281.
Google Scholar
Studenic P, Radner H, Smolen JS, Aletaha D. Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity. Arthritis Rheum. 2012;64:2814–23.
Article
PubMed
Google Scholar
Therapeutic Goods of Australia. Xeljanz. Product Information https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2015-PI-01192-1&d=201903271016933. Accessed 1 Nov 2019.
Therapeutic Goods of Australia. Olumiant. Product Information https://www.tga.gov.au/sites/default/files/auspar-baricitinib-190321-pi.pdf. Accessed 1 Nov 2019.
JKA d B, Gonzalez E, Lopez-Olivo MA, Shethia M, Nayak P, Suarez-Almazor ME. Assessing information needs and use of online resources for disease self-management in patients with rheumatoid arthritis: a qualitative study. Clin Rheumatol. 2018 Jul;37(7):1791–7. https://doi.org/10.1007/s10067-018-4047-9.
Article
Google Scholar
Jimenez-Liñan LM, Edwards L, Abhishek A, Doherty M. Adequacy of online patient information resources on gout and potentially curative Urate-lowering treatment. Arthritis Care Res. 2017:748–52. https://doi.org/10.1002/acr.22981.